Wei Donglei, Jung Jinsuh, Yang Huilin, Stout David A, Yang Lei
Orthopaedic Institute, Department of Orthopaedics, The First Affiliated Hospital, Soochow University, Suzhou, 215006, Jiangsu, People's Republic of China.
International Research Center for Translational Orthopaedics (IRCTO), Soochow University, Suzhou, 215006, Jiangsu, People's Republic of China.
Curr Osteoporos Rep. 2016 Oct;14(5):239-47. doi: 10.1007/s11914-016-0324-1.
Unfortunately, osteoporosis, as a worldwide disease, is challenging human health with treatment only available for the symptoms of osteoporosis without managing the disease itself. Osteoporosis can be linked as the common cause of fractures and increased mortality among post-menopausal women, men, and the elderly. Regrettably, due to osteoporosis, incidents of fractures are more frequent among the presented populations and can be afflictive for carrying out everyday life activities. Current treatments of osteoporosis encompass changing lifestyles, taking orthopedic drugs, and invasive surgeries. However, these treatment options are not long lasting and can lead to complications after post-surgical life. Therefore, to solve this impairment, researchers have turned to nanotechnologies and nanomaterials to create innovative and alternative treatments associated with the consequences of osteoporosis. This review article provides an introduction to osteoporotic compression vertebral fractures (OVCFs) and current clinical treatments, along with the rationale and efficacy of utilizing nanomaterials to modify and improve biomaterials or instruments. The methods of applying bioactive agents (bone morphogenetic protein-2 (BMP-2), parathyroid hormone 1-34 (PTH 1-34)), as well as 3D printing will be presented from an osteoporosis treatment perspective. Additionally, the application of nanoparticles and nanotube arrays onto the current surgical treatments and orthopedic drug administration methods addressed will show that these systems reinforce a better mechanical performance and provide precise and slow-releasing drug delivery for better osseointegration, bone regeneration, and bone strength. In summary, nanomaterials can be seen as an alternative and more effective treatment for individuals with osteoporosis.
不幸的是,骨质疏松症作为一种全球性疾病,正挑战着人类健康,目前的治疗方法仅针对骨质疏松症的症状,而无法治愈该疾病本身。骨质疏松症可被视为绝经后女性、男性和老年人骨折及死亡率增加的常见原因。遗憾的是,由于骨质疏松症,上述人群中骨折的发生率更高,且会影响日常生活活动。目前骨质疏松症的治疗方法包括改变生活方式、服用矫形药物和进行侵入性手术。然而,这些治疗选择效果不持久,术后还可能导致并发症。因此,为了解决这一问题,研究人员已转向纳米技术和纳米材料,以创造与骨质疏松症后果相关的创新替代疗法。本文综述介绍了骨质疏松性椎体压缩骨折(OVCFs)及当前的临床治疗方法,以及利用纳米材料改性和改进生物材料或器械的原理和功效。将从骨质疏松症治疗的角度介绍应用生物活性剂(骨形态发生蛋白-2(BMP-2)、甲状旁腺激素1-34(PTH 1-34))以及3D打印的方法。此外,将纳米颗粒和纳米管阵列应用于当前的手术治疗和矫形药物给药方法将表明,这些系统可增强更好的机械性能,并提供精确且缓释的药物递送,以实现更好的骨整合、骨再生和骨强度。总之,纳米材料可被视为骨质疏松症患者的一种替代且更有效的治疗方法。